LUPRODEX 22.5

About

LUPRODEX 22.5 contains Leuprolide Acetate, a synthetic gonadotropin-releasing hormone (GnRH) agonist. Its primary action involves an initial stimulation of the pituitary gland, leading to a transient increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH). However, with continuous exposure, the GnRH receptors on the pituitary become desensitized, resulting in a profound and sustained suppression of LH and FSH release. This ultimately leads to a significant reduction in the production of gonadal steroids, such as testosterone in men and estrogen in women, effectively achieving a state of medical castration.

This sustained hormonal suppression is crucial for the management of various hormone-sensitive conditions. The 22.5 mg formulation is designed for prolonged release, providing consistent therapeutic effects over a three-month period, which offers significant convenience and improved adherence for patients compared to more frequent dosing regimens.

Uses

• Treatment of advanced prostate cancer.
• Management of endometriosis.
• Treatment of uterine fibroids.
• Management of central precocious puberty.

Directions For Use

Administer as a subcutaneous or intramuscular injection once every three months. Follow healthcare provider's instructions precisely.

Benefits

• Long-acting formulation, convenient quarterly dosing.
• Effective and sustained suppression of sex hormones.
• Reduces tumor burden and symptoms in prostate cancer.
• Provides significant relief from endometriosis symptoms.
• Helps shrink uterine fibroids.
• Manages precocious puberty effectively with fewer injections.

Side Effects

• Hot flashes
• Sweating
• Decreased libido
• Erectile dysfunction (men)
• Vaginal dryness (women)
• Bone density loss
• Injection site reactions
• Headache
• Mood changes
• Fatigue
• Muscle pain
• Weight changes

Safety Measures

• Alcohol - No specific contraindication, but may worsen hot flashes or mood swings in some individuals.
• Pregnancy - Absolutely contraindicated in pregnancy due to high risk of fetal harm. Ensure negative pregnancy test before initiation.
• Breastfeeding - Not recommended during breastfeeding as it may interfere with infant's hormonal development.
• Liver - Use with caution in patients with hepatic impairment; monitor liver function periodically.
• Kidney - Generally considered safe in renal impairment; no specific dose adjustment typically needed.
• Lung - No direct pulmonary effects, but monitor for any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.